AtriCure Inc. has closed a deal for Endoscopic Technologies Inc.

San Ramon, Calif.-based Endoscopic Technologies, which does business as Estech, develops and markets a group of surgical devices that physicians use in minimally invasive procedures to treat abnormal heart beats. The purchase price includes $34 million in AtriCure common stock and up to $26 million in additional payments based on achievement of milestones.

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.